The same group could substantiate the evidence for a radiosensitizing effect of MEHD7945A using human lung and head and neck cancer cells as well as xenografts further supporting the clinical implementation of this EGFR/HER3 combined targeting approach (29). The gene discussed is ERBB3; the disease is head and neck cancer.